STOCK TITAN

Braunstein backs Talkspace (TALK) sale, locking 14.9% stake for UHS deal

Filing Impact
(Moderate)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13D/A

Rhea-AI Filing Summary

Talkspace, Inc. large shareholder Douglas L. Braunstein and affiliated Hudson Executive Capital entities updated their Schedule 13D to reflect a new merger and voting commitment. Braunstein reports beneficial ownership of 26,259,940 shares of Talkspace common stock, or 14.9% of the company’s outstanding shares, including warrants and options exercisable within 60 days and shares held jointly with his spouse.

Hudson Executive Capital–related entities each report beneficial ownership of 18,980,600 shares, or 11% of the common stock, including 7,640,000 shares issuable upon exercise of warrants within 60 days. The amendment discloses that on March 9, 2026, Talkspace agreed to merge with Universal Health Services, Inc. through a merger subsidiary, after which Talkspace will become an indirect wholly owned subsidiary.

On the same date, certain of these reporting persons entered into a Voting Agreement with Universal Health Services. They agreed to vote all their Talkspace shares in favor of adopting the Merger Agreement and related actions, against any alternative takeover proposal, and against actions reasonably expected to materially impede or prevent the merger. The Voting Agreement terminates upon the earliest of the Merger Agreement’s termination, the merger’s effectiveness, specified adverse amendments to merger consideration without the holders’ consent, or mutual agreement with the parent for a given holder.

Positive

  • None.

Negative

  • None.

Insights

Large Talkspace holder formally backs sale to Universal Health Services.

The filing shows Douglas L. Braunstein controlling 14.9% of Talkspace on a fully diluted basis, with affiliated Hudson Executive Capital entities each at 11%. This is a concentrated, influential position in a relatively small-cap issuer.

The amendment’s key change is a Voting Agreement tied to the March 9, 2026 Merger Agreement with Universal Health Services. These holders commit their full positions to support the merger, oppose competing takeover bids, and vote against actions that could delay or block the deal.

This level of locked-up support from a large shareholder materially increases the likelihood that the merger secures stockholder approval. Actual outcomes will depend on remaining shareholder votes, regulatory clearances, and the Merger Agreement’s closing conditions as described in related company disclosures.






Douglas L. Braunstein
Hudson Executive Capital LP, c/o Talkspace, Inc., 622 Third Avenue
New York, NY, 10017
212-284-7206

(Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)
03/09/2026

(Date of Event Which Requires Filing of This Statement)


If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box.

The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).






SCHEDULE 13D




Comment for Type of Reporting Person:
Note to Rows 8 and 10: Inclusive of 7,640,000 shares beneficially owned through the ownership of warrants exercisable within 60 days of the date of this Schedule 13D. Note to Row 13: Percentage beneficial ownership is based on 165,656,124 shares of the Issuer's common stock, $0.0001 par value per share ("Common Stock"), outstanding as of November 4, 2025, as reported in the Issuer's Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission (the "SEC") on November 6, 2025, together with 7,640,000 shares of Issuer's Common Stock issuable upon the exercise of warrants owned by the Reporting Person named above.


SCHEDULE 13D




Comment for Type of Reporting Person:
Note to Rows 8 and 10: Inclusive of 7,640,000 shares beneficially owned through the ownership of warrants exercisable within 60 days of the date of this Schedule 13D. Note to Row 13: Percentage beneficial ownership is based on 165,656,124 shares of the Issuer's Common Stock, outstanding as of November 4, 2025, as reported in the Issuer's Quarterly Report on Form 10-Q filed with the SEC on November 6, 2025, together with 7,640,000 shares of Issuer's Common Stock issuable upon the exercise of warrants owned by the Reporting Person named above.


SCHEDULE 13D




Comment for Type of Reporting Person:
Note to Rows 8 and 10: Inclusive of 7,640,000 shares beneficially owned through the ownership of warrants exercisable within 60 days of the date of this Schedule 13D. Note to Row 13: Percentage beneficial ownership is based on 165,656,124 shares of the Issuer's Common Stock, outstanding as of November 4, 2025, as reported in the Issuer's Quarterly Report on Form 10-Q filed with the SEC on November 6, 2025, together with 7,640,000 shares of Issuer's Common Stock issuable upon the exercise of warrants owned by the Reporting Person named above.


SCHEDULE 13D




Comment for Type of Reporting Person:
Note to Rows 7 and 9: Inclusive of (a) 2,274,446 shares of Issuer's Common Stock owned jointly among Mr. Braunstein and his spouse, including through a trust, (b) 2,270,000 shares beneficially owned through the ownership of warrants exercisable within 60 days of the date of this Schedule 13D owned jointly among Mr. Braunstein and his spouse and (c) 703,402 shares underlying certain options exercisable within 60 days of the date of this Schedule 13D. Note to Rows 8 and 10: Inclusive of 7,640,000 shares beneficially owned through the ownership of warrants exercisable within 60 days of the date of this Schedule 13D. Note to Row 13: Percentage beneficial ownership is based on 165,656,124 shares of the Issuer's Common Stock outstanding as of November 4, 2025, as reported in the Issuer's Quarterly Report on Form 10-Q filed with the SEC on November 6, 2025, together with 9,910,000 shares of Issuer's Common Stock issuable upon the exercise of warrants owned by the Reporting Person named above and 703,402 shares of Issuer's Common Stock underlying certain options owned by the Reporting Person named above.


SCHEDULE 13D


HEC Management GP LLC
Signature:/s/ Douglas L. Braunstein
Name/Title:Douglas L. Braunstein, Managing Member
Date:03/10/2026
Hudson Executive Capital LP
Signature:/s/ Douglas L. Braunstein
Name/Title:Douglas L. Braunstein, Managing Member
Date:03/10/2026
HEC Master Fund LP
Signature:/s/ Douglas L. Braunstein
Name/Title:Douglas L. Braunstein, Investment Manager
Date:03/10/2026
Douglas L. Braunstein
Signature:/s/ Douglas L. Braunstein
Name/Title:Douglas L. Braunstein
Date:03/10/2026

FAQ

How many Talkspace (TALK) shares does Douglas L. Braunstein beneficially own?

Douglas L. Braunstein reports beneficial ownership of 26,259,940 Talkspace common shares, representing 14.9% of the company. This total includes jointly held shares with his spouse, warrants and options exercisable within 60 days, and shares held through related entities.

What is Hudson Executive Capital’s ownership stake in Talkspace (TALK)?

Hudson Executive Capital–related entities each report beneficial ownership of 18,980,600 Talkspace common shares, representing 11% of the class. This figure includes 7,640,000 shares issuable upon exercise of warrants that are exercisable within 60 days of the filing date.

What merger involving Talkspace (TALK) is described in this Schedule 13D/A?

The filing describes a Merger Agreement dated March 9, 2026, under which a subsidiary of Universal Health Services, Inc. will merge with Talkspace. After completion, Talkspace will survive as an indirect wholly owned subsidiary of Universal Health Services.

What does the Voting Agreement require Talkspace (TALK) holders to do?

Under the Voting Agreement, certain reporting persons agree to vote all their Talkspace shares in favor of adopting the Merger Agreement, against any alternative takeover proposal, and against actions reasonably expected to materially impede, delay, or prevent consummation of the merger transactions.

When does the Talkspace (TALK) Voting Agreement terminate?

The Voting Agreement terminates on the earliest of: valid termination of the Merger Agreement, the merger’s Effective Time, specified adverse amendments to merger consideration without the applicable holder’s consent, or mutual written agreement between the applicable holder and Universal Health Services.

How is the 14.9% beneficial ownership for Talkspace (TALK) calculated?

The 14.9% figure is based on 165,656,124 Talkspace shares outstanding as of November 4, 2025, plus 9,910,000 shares issuable upon warrant exercise and 703,402 shares underlying options held by Braunstein that are exercisable within 60 days of the filing.
Talkspace Inc

NASDAQ:TALK

View TALK Stock Overview

TALK Rankings

TALK Latest News

TALK Latest SEC Filings

TALK Stock Data

848.16M
158.69M
Health Information Services
Services-health Services
Link
United States
NEW YORK